Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12410941 | PMC |
| http://dx.doi.org/10.5603/cj.102360 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Characterization of a 0.5 × 0.5 mm plastic scintillating detector for small field dosimetry: Its performance and comparison with other commercially available plastic scintillating detectors.
J Appl Clin Med Phys
September 2025
Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Background: Lack of an ideal detector for small field dosimetry has led to the development of many new types of detectors. Recent studies have shown that plastic scintillation detectors (PSDs) provide favorable dosimetric characteristics, such as minimal volume averaging and fluence perturbation effects, real time response rates, high signal to noise ratio (SNR), and independence to temperature, energy spectrum, dose rate, and irradiation direction, in the field of small field dosimetry, largely due to their small size and water-equivalent composition materials, which eliminates the need for certain correction factors.
Purpose: The goal of this study was to evaluate a new 0.
Radiotherapy quality assurance program of ongoing clinical trial using stereotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC): a dummy run study of a prospective, randomized, multicenter phase III trial (KGOG 3064/KROG 2204).
BMC Cancer
August 2025
Department of Radiation Oncology, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.
Background: Recurrent ovarian cancer is often treated with chemotherapy, but many patients experience multiple recurrences with progressively shorter intervals and poorer prognosis. Repeated chemotherapy reduces patients' quality of life. Stereotactic Ablative Radiation Therapy for Recurrent Ovarian Cancer (SABR-ROC) (KGOG3064/KROG 2204) is an ongoing trial investigating the clinical efficacy of stereotactic ablative radiation therapy (SABR) for recurrent ovarian cancer.
View Article and Find Full Text PDFRepeated stereotactic radiosurgery for high grade meningioma.
J Neurooncol
August 2025
Department of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan.
Background And Objectives: Atypical and anaplastic meningioma (World Health organization [WHO] Grades II and III) present therapeutic challenges due to their aggressive behavior and high risk of recurrence. This study addressed the lack of data related to the effectiveness and safety of repeated stereotactic radiosurgery (SRS) in managing high-grade recurrent or residual meningioma.
Methods: This study analyzed data extracted from the medical records of 112 patients (mean age of 57.
PSMA response evaluation in follow-up PSMA-PET/CT after stereotactic ablative body radiotherapy (SABR) for oligometastases in prostate cancer.
Clin Transl Radiat Oncol
September 2025
Department of Radiotherapy, University Hospital Schleswig-Holstein, Campus Kiel, Arnold-Heller-Str. 3, 24105 Kiel, Germany.
Purpose: PSMA-PET/CT is frequently used for staging patients with de-novo or recurrent prostate cancer (PCa). In patients with oligometastatic PCa PSMA-PET/CT guided stereotactic ablative body radiotherapy (SABR) is a common treatment option. Follow-up is regularly performed via measurement of prostate-specific-antigen (PSA) level.
View Article and Find Full Text PDFAn anaplastic ependymoma with chondroid metaplasia after stereotactic radiosurgery: illustrative case.
J Neurosurg Case Lessons
August 2025
Department of Neurosurgery, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Aichi Prefecture, Japan.
Background: Anaplastic ependymomas are malignant CNS tumors with poor prognosis. Chondroid metaplasia in ependymomas is extremely rare, and its clinical significance remains unclear.
Observations: A 21-year-old male underwent gross-total resection and adjuvant radiotherapy for an anaplastic ependymoma.